Literature DB >> 19184348

Interleukin 10 promoter region polymorphisms in inflammatory bowel disease in Tunisian population.

R Marrakchi1, A Moussa, S Ouerhani, K Bougatef, R Bouhaha, Y Messai, K Rouissi, I Khadimallah, H Khodjet-el-Khil, T Najar, A Benammar-Elgaaeid.   

Abstract

OBJECTIVE: To test whether IL-10 promoter region polymorphisms are associated with susceptibility to inflammatory bowel disease, we examined the contribution of interleukin- 10 (IL-10) gene polymorphisms to Crohn's disease (CD) and Ulcerative colitis disease (UC) occurrence and also to CD phenotype. MATERIELS AND METHODS: SNPs at positions -627 (C > A) and -1117 (G > A) in the IL-10 promoter were determined in a sample of 105 Tunisian patients with IBD (75 CD and 30 UC) and 90 matched healthy controls.
RESULTS: The 627 CA genotype is associated with ileal location (p = 0.015) and with stricturing (p = 510-3) and penetrating (p = 310-3) presentation of CD. An additive effect between IL10 variants and CARD15 3020 insC mutation (p = 0,006) on severe forms of CD was shown.
CONCLUSIONS: In Tunisian population, the 3020insC insertion in NOD2/CARD15 gene is a marker of susceptibility to CD, while the A allele at position -627 in the IL-10 promoter increases the risk of CD ileal location and severe disease presentation. A genetic epistasis between IL-10 gene polymorphisms and CARD15/NOD2 gene mutation was suggested.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19184348     DOI: 10.1007/s00011-008-8265-5

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  4 in total

Review 1.  Associations between CD24 gene polymorphisms and inflammatory bowel disease: A meta-analysis.

Authors:  Xiao-Li Huang; Dong-Hua Xu; Guo-Pin Wang; Shu Zhang; Cheng-Gong Yu
Journal:  World J Gastroenterol       Date:  2015-05-21       Impact factor: 5.742

Review 2.  Genetic update on inflammatory factors in ulcerative colitis: Review of the current literature.

Authors:  Patricia Sarlos; Erzsebet Kovesdi; Lili Magyari; Zsolt Banfai; Andras Szabo; Andras Javorhazy; Bela Melegh
Journal:  World J Gastrointest Pathophysiol       Date:  2014-08-15

3.  A novel mouse model of inflammatory bowel disease links mammalian target of rapamycin-dependent hyperproliferation of colonic epithelium to inflammation-associated tumorigenesis.

Authors:  Lin Deng; Jin-Feng Zhou; Rani S Sellers; Jiu-Feng Li; Andrew V Nguyen; Yubao Wang; Amos Orlofsky; Qiang Liu; David A Hume; Jeffrey W Pollard; Leonard Augenlicht; Elaine Y Lin
Journal:  Am J Pathol       Date:  2009-12-30       Impact factor: 4.307

Review 4.  Interleukin and interleukin receptor gene polymorphisms in inflammatory bowel diseases susceptibility.

Authors:  Lili Magyari; Erzsebet Kovesdi; Patricia Sarlos; Andras Javorhazy; Katalin Sumegi; Bela Melegh
Journal:  World J Gastroenterol       Date:  2014-03-28       Impact factor: 5.742

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.